Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC15A1 | P46059 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | IDO1 | P14902 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | CDC25B | P30305 | 1/20 | 0.48 |
| ▸ | LTA4H | P09960 | 1/20 | 0.47 |
| ▸ | LAP3 | P28838 | 1/20 | 0.47 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.46 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.46 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL589202 | 1.00 | SLC15A1 (0.61) | SLC15A1ALDH1A1MAPK1L3MBTL1IDO1 | |
| SCHEMBL1264374 | 1.00 | SLC15A1 (0.61) | SLC15A1ALDH1A1MAPK1L3MBTL1IDO1 | |
| SCHEMBL32681189 | 1.00 | SLC15A1 (0.61) | SLC15A1ALDH1A1MAPK1L3MBTL1IDO1 | |
| Hydrochloric Acid SCHEMBL29401429 | 0.98 | SLC15A1 (0.59) | SLC15A1ALDH1A1MAPK1L3MBTL1IDO1 | |
| Hydrochloric Acid SCHEMBL16987449 | 0.98 | SLC15A1 (0.59) | SLC15A1ALDH1A1MAPK1L3MBTL1IDO1 | |
| Hydrochloric Acid SCHEMBL14762001 | 0.98 | SLC15A1 (0.59) | SLC15A1ALDH1A1MAPK1L3MBTL1IDO1 | |
| SCHEMBL28820464 | 0.92 | SLC15A1 (0.52) | SLC15A1ALDH1A1MAPK1L3MBTL1IDO1 | |
| Aspartic Acid SCHEMBL28852564 | 0.91 | SLC15A1 (0.56) | SLC15A1ALDH1A1MAPK1L3MBTL1IDO1 | |
| SCHEMBL28154515 | 0.91 | SLC15A1 (0.52) | SLC15A1ALDH1A1MAPK1L3MBTL1IDO1 | |
| SCHEMBL8413846 | 0.91 | SLC15A1 (0.56) | SLC15A1ALDH1A1MAPK1L3MBTL1IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 471 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4674441-A1 | RARE EARTH NANO FLUORESCENCE-NUCLEAR MEDICINE TUMOR TOMOGRAPHY-THERAPY INTEGRATED PREPARATION, PREPARING METHOD THEREFOR, AND USE METHOD AND USE THEREOF | Zhongke Rare Earth Nanotechnology (Hebei) Co., Ltd (CN) | 2026-01-07 | — | — | EP | claimed |
| CN-119454742-A | Nanometer medicine for inhibiting macrophage cytokinesis through hybrid cell membrane modification, and preparation method and application thereof | 广州医科大学附属第二医院 | 2025-02-18 | — | — | CN | claimed |
| CN-114672003-B | Conjugated polymer based on thiophene [3,4-c ] pyrrole-4, 6-dione structure, and preparation method and application thereof | 天津理工大学 | 2024-10-01 | — | — | CN | claimed |
| CN-116459165-B | Polyethylene glycol-polyaspartic acid-alendronic acid polymer coating material for preventing and treating dental caries, and preparation method and application thereof | 成都爱睿康乐医疗器械有限公司 | 2024-07-26 | — | — | CN | claimed |
| CN-118108743-A | Near infrared two-region fluorescent molecule, nano targeting fluorescent probe, and preparation methods and applications thereof | 复旦大学 | 2024-05-31 | — | — | CN | claimed |
| CN-117838727-A | Temperature-sensitive hydrogel and preparation method and application thereof | 华中农业大学 | 2024-04-09 | — | — | CN | claimed |
| CN-117757896-A | Kit for rapidly concentrating African swine fever virus in wastewater and virus concentration method | 苏州先进分子诊断技术有限公司 | 2024-03-26 | — | — | CN | claimed |
| CN-117624557-A | Conjugated polymer photocatalyst with double sulfonyl structure, and preparation method and application thereof | 天津理工大学 | 2024-03-01 | — | — | CN | claimed |
| CN-112675148-B | Multifunctional high-efficiency drug delivery system and preparation method and application thereof | 内蒙古民族大学 | 2023-08-11 | — | — | CN | claimed |
| CN-112870374-B | Preparation of sugar-responsive functionalized nano-composite micelle and application thereof in insulin delivery | 南开大学 | 2023-08-08 | — | — | CN | claimed |
| EP-1372618-B1 | COLLOIDAL SUSPENSION OF NANOPARTICLES BASED ON AN AMPHIPHILIC COPOLYMER | FLAMEL TECH SA (FR) | 2012-12-05 | — | — | EP | claimed |
| US-20120148631-A1 | PEGYLATED POLYPLEXES FOR POLYNUCLEOTIDE DELIVERY | INTEZYNE TECHNOLOGIES, INCORPORATED (US) | 2012-06-14 | — | — | US | claimed |
| CN-101497615-B | Substituted purine, preparation and use in medicine | ZHEJIANG MED XINCHANG PHARM | 2010-12-15 | — | — | CN | claimed |
| US-7638558-B2 | drug loaded micelle of a triblock polymer tert-butylphenylsilylpropene-polyethylene glycol-b-poly(tert-butylaspartic acid-b-polyphenylalanine-copoly( tert-buyltyrosine) has a drug-loaded inner core, a crosslinked outer core, and a hydrophilic shell | INTEZYNE TECHNOLOGIES, INC. (US) | 2009-12-29 | — | — | US | claimed |
| CN-101597290-A | β-Ka Lin-3-formyl tryptophyl amino-acid benzyl ester and its production and application | UNIV CAPITAL MEDICAL (CN) | 2009-12-09 | — | — | CN | claimed |
| CN-101497615-A | Substituted purine, preparation and use in medicine | XINCHANG PHARMACEUTICAL FACTORY ZHEJIANG MEDICINE CO LTD (CN) | 2009-08-05 | — | — | CN | claimed |
| EP-1322411-B1 | COLLOIDAL SUSPENSION OF SUBMICRONIC PARTICLES FOR CARRYING ACTIVE PRINCIPLES AND THEIR MODE OF PREPARATION | FLAMEL TECH SA (FR) | 2007-01-17 | — | — | EP | claimed |
| US-20040138095-A1 | Colloidal suspension of nanoparticles based on an amphiphilic copolymer | FLAMEL IRELAND LIMITED (IE) | 2004-07-15 | — | — | US | claimed |
| US-20040048782-A1 | Colloidal suspension of submicronic particles for carrying hydrophilic active principles (insulin) and method for preparing same | FLAMEL TECHNOLOGIES (FR) | 2004-03-11 | — | — | US | claimed |
| US-20040038885-A1 | Colloidal suspension of submicronic particles for carrying active principles and their mode of preparation | DEERFIELD PRIVATE DESIGN FUND II, L.P. | 2004-02-26 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120148631-A1 | PEGYLATED POLYPLEXES FOR POLYNUCLEOTIDE DELIVERY | PARN, PUF60, PARG | SLC15A1 1944/4885ALDH1A1 4268/4885MAPK1 4294/4885 |
| US-20040138095-A1 | Colloidal suspension of nanoparticles based on an amphiphilic copolymer | IAPP, INSR, IGFBP3 | SLC15A1 2138/4885ALDH1A1 3572/4885MAPK1 2402/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.